The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Open accessAbstract
miR-33 in Cholesterol Control: With the well-established link between serum cholesterol levels and cardiovascular disease and the availability of effective cholesterol-lowering drugs, cholesterol screening has rapidly become a routine part of health care. Yet, much remains to be learned about how cholesterol levels are regulated at the cellular level (see the Perspective by Brown et al. ). Now, Najafi-Shoushtari et al. (p. 1566 , published online 13 May) and Rayner et al. (p. 1570 , published online 13 May) have discovered a new molecular player in cholesterol control—a small noncoding RNA that, intriguingly, is embedded within the genes coding for sterol regulatory element-binding proteins (SREBPs), transcription factors already known to regulate cholesterol levels. This microRNA, called miR-33, represses expression of the adenosine triphosphate–binding cassette transporter A1, a protein that regulates synthesis of high-density lipoprotein (HDL, or “good” cholesterol) and that helps to remove “bad” cholesterol from the blood. Reducing the levels of miR-33 in mice boosted serum HDL levels, suggesting that manipulation of this regulatory circuit might be therapeutically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological inhibition of miR-33 increased plasma high-density lipoprotein cholesterol levels in mice (Horie et al., 2010;Najafi-Shoushtari et al., 2010;Rayner et al., 2011a) and primates (Rayner et al., 2011b;Rottiers et al., 2013), leading to a marked reduction of atherosclerosis phenotypes.”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in vivo antagonism or genetic deletion of miR-33 enhances hepatic ABCA1 expression and increases circulating HDL-cholesterol (HDL-C) (Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These differences in miRNA expression vary between cell types suggesting that the role of miR-33b in the liver, where miR-33 is most highly expressed both in our mouse model and in human tissues (Najafi-Shoushtari et al., 2010), and other tissues may be considerably more important.”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In miR-33a knockout mice or when miR-33a is suppressed by synthetic nucleic acids such as antagomirs, the expression of ABCA1 in macrophages and the liver is increased 11 - 15) .”
From Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MicroRNA (miR)-33 is known to target ABCA1 and ABCG1 in vivo.”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [17]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two miR-33 genes are present in humans: miR-33b, which is present in intron 17 of the Srebp-1 gene on chromosome 17, and miR-33a, which is located in intron 16 of the Srebp-2 gene on chromosome 22.”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We and others have recently established that, during sterol-limited states, miR-33a is coincidentally generated with Srebp-2 transcription and works to increase cellular cholesterol levels by limiting cholesterol export through the down-regulation of ABC transporters, ABCA1 and ABCG1 (12–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“miR-33a and miR-33b are intronic miRNAs encoded within the SREBP-2 and SREBP-1 genes respectively (Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“This work led to the demonstration that miR-33a and miR-33b are co-transcribed along with SREBP-2 and SREBP-1, and work in concert with their host genes to help maintain proper lipid levels within the cell (Davalos et al., 2011; Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“The most well-known target gene of miR-33a/b is ATP-binding cassette subfamily A member 1 (ABCA1).”
From Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives (2026) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Recent reports, including ours, have indicated that miR-33 controls cholesterol homeostasis based on knockdown experiments using antisense technology.16–18”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“We and others provided identification of a highly conserved miRNA family, miR-33, within the intronic sequences of the Srebp genes in organisms ranging from Drosophila to humans (11–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“In mice, however, there is only one miR-33 gene, which is conserved with human miR-33a and located within intron 15 of the mouse Srebp-2 gene.”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, these pathways regulate circulating HDL levels through their roles in HDL biogenesis and cellular cholesterol efflux (12–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
In the citing paper
“These microRNAs participate in the regulation of cholesterol synthesis, fatty acid metabolism, and insulin signaling.”
From The Vasculature in Prediabetes (2018) · cites this paper as [143]
In the citing paper
“They are co-transcribed and act in conjunction with their host genes, Srebp1 and Srebp2, to regulate cholesterol synthesis.”
From The Vasculature in Prediabetes (2018) · cites this paper as [143]
In the citing paper
“Furthermore, an intronic microRNA located within Srebf2 gene, miR-33, inhibits the expression of Abca1 (Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Identification of Mammalian microRNA Host Genes and Transcription Units
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., & Bradley, A. (2004) · Genome Research · doi:10.1101/gr.2722704 · Cited by 2,128
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1172/jci0215748 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 957
MicroRNAs in lipid metabolism and atherosclerosis
Giral, H., Kratzer, A., & Landmesser, U. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.010 · Cited by 56
MicroRNAs and metabolic disorders – where are we heading?
Śliwińska, A., Kasińska, M., & Drzewoski, J. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.65229 · Cited by 55
Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins
Singh, A. K., Aryal, B. K., Zhang, X., Fan, Y., Price, N. L., Suárez, Y., & Fernandez-Hernando, C. F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.026 · Cited by 55
Perspective: Milk microRNAs as Important Players in Infant Physiology and Development
Leroux, C., Chervet, M., & German, J. B. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab059 · Cited by 55
Tarling, E. J., & Edwards, P. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.011 · Cited by 56
Non-coding RNAs in lipid metabolism
Zhang, X., Price, N. L., & Fernandez-Hernando, C. F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.011 · Cited by 54
Stamatikos, A., Knight, E., Vojtech, L. N., Bi, L., Wacker, B. K., Tang, C., & Dichek, D. A. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.245 · Cited by 54
miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques
Afonso, M. S., Sharma, M., Schlegel, M., van Solingen, C., Koelwyn, G. J., Shanley, L. C., Beckett, L., Peled, D., Rahman, K., Giannarelli, C., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317914 · Cited by 53
MicroRNAs as immune regulators and biomarkers in tuberculosis
Wang, L., Xiong, Y., Fu, B., Guo, D. S., Zaky, M. Y., Lin, X., & Wu, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1027472 · Cited by 56
Box C/D Small Nucleolar RNA (snoRNA) U60 Regulates Intracellular Cholesterol Trafficking
Brandis, K. A., Gale, S. E., Jinn, S., Langmade, S. J., Dudley-Rucker, N., Jiang, H., Sidhu, R., Ren, A. A., Goldberg, A., Schaffer, J. E., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.488577 · Cited by 60
Epigenetic-Dependent Regulation of Drug Transport and Metabolism: An Update
Kacevska, M., Ivanov, M., & Ingelman‐Sundberg, M. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.119 · Cited by 55
Human genetics of HDL: Insight into particle metabolism and function
Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 54
Complexity of microRNA function and the role of isomiRs in lipid homeostasis
Vickers, K. C., Sethupathy, P., Baran‐Gale, J., & Remaley, A. T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r034801 · Cited by 53
Huang, K., Bao, H., Yan, Z., Wang, L., Zhang, P., Yao, Q., Shi, Q., Chen, X., Wang, K., Shen, B., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvw257 · Cited by 52
Role of Non-Coding RNAs in Stroke
Tiedt, S., & Dichgans, M. (2018) · Stroke · doi:10.1161/strokeaha.118.021010 · Cited by 52
Chung, E. J., & Tirrell, M. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500126 · Cited by 51
Novák, J., Vašků, J. B., Kára, T., & Novák, M. (2014) · Mediators of Inflammation · doi:10.1155/2014/275867 · Cited by 53
Functions of microRNA-33a/b and microRNA therapeutics
Ono, K. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.10.017 · Cited by 52
Exosomes in Cardiovascular Disease: From Mechanism to Therapeutic Target
Reiss, A. B., Ahmed, S., Johnson, M., Saeedullah, U., & Leon, J. D. (2023) · Metabolites · doi:10.3390/metabo13040479 · Cited by 54
Dávalos, A., & Fernandez-Hernando, C. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.005 · Cited by 52
Mao, M., Lei, H., Liu, Q., Chen, Y., Zhao, L., Li, Q., Luo, S., Zuo, Z., He, Q., Huang, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109722 · Cited by 53
Role of microRNA-30c in lipid metabolism, adipogenesis, cardiac remodeling and cancer
Irani, S., & Hussain, M. M. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000162 · Cited by 50
Price, N. L., Zhang, X., Fernández-Tussy, P., Singh, A. K., Burnap, S. A., Rotllan, N., Goedeke, L., Sun, J., Canfrán-Duque, A., Aryal, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006478118 · Cited by 50
Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Nakazeki, F., Ide, Y., et al. (2014) · Scientific Reports · doi:10.1038/srep05312 · Cited by 49
microRNAs: A connection between cholesterol metabolism and neurodegeneration
Goedeke, L., & Fernandez-Hernando, C. F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.034 · Cited by 49
Selitsky, S. R., Dinh, T. A., Toth, C. L., Kurtz, C. L., Honda, M., Struck, B. R., Kaneko, S., Vickers, K. C., Lemon, S. M., & Sethupathy, P. (2015) · mBio · doi:10.1128/mbio.01500-15 · Cited by 49
Wang, Y., Liu, C., & Hu, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.123 · Cited by 49
microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
Horie, T., Nakao, T., Miyasaka, Y., Nishino, T., Matsumura, S., Nakazeki, F., Ide, Y., Kimura, M., Tsuji, S., Rodriguez, R. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21107-5 · Cited by 49
Fisetin protects against hepatosteatosis in mice by inhibiting miR-378
Jeon, T., Park, J. W., Ahn, J., Jung, C. H., & Ha, T. Y. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300071 · Cited by 47
Genomewide analysis of intronic microRNAs in rice and Arabidopsis
Yang, G., Yan, K., Wu, B., et al. (2012) · Journal of Genetics · doi:10.1007/s12041-012-0199-6 · Cited by 48
Sterol Metabolism and Transport in Atherosclerosis and Cancer
Yamauchi, Y., & Rogers, M. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00509 · Cited by 52
miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis
Huang, C., Sun, C., Zhao, F., Zhang, Y., & Li, D. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0986-3 · Cited by 47
microRNAs and cancer metabolism reprogramming: the paradigm of metformin.
Pulito, C., Donzelli, S., Muti, P. C., Puzzo, L., Strano, S., & Blandino, G. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.03 · Cited by 49
Current concept of reverse cholesterol transport and novel strategy for atheroprotection
Ono, K. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.07.014 · Cited by 49
Biological roles of microRNAs in the control of insulin secretion and action
Caldérari, S., Diawara, M. R., Garaud, A., & Gauguier, D. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00079.2016 · Cited by 50
Insight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 48
Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease
Araldi, E., Chamorro-Jorganes, A., Solingen, C. V., Fernandez-Hernando, C. F., & Suárez, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990012 · Cited by 47
Steen, V. M., Skrede, S., Polushina, T. V., López, M., Andreassen, O. A., Fernø, J., & Hellard, S. L. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.07.011 · Cited by 48
Zhu, T., Corraze, G., Plagnes-Juan, E., Quillet, E., Dupont-Nivet, M., & Skiba-Cassy, S. (2018) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00179.2017 · Cited by 45
Feng, Y., Qu, X., Chen, Y., Feng, Q., Zhang, Y., Hu, J., & Li, X. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00618-8 · Cited by 46
Long non-coding RNA H19 in atherosclerosis: what role?
Shi, X., Wei, Y., Li, H., Jiang, T., Zheng, X., Yin, K., & Zhao, G.-J. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00196-w · Cited by 47
miRNA regulation of LDL-cholesterol metabolism
Goedeke, L., Wagschal, A., Fernández-Hernando, C., & Näär, A. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.007 · Cited by 39
Self-citationMizuno, T., Hayashi, H., Naoi, S., & Sugiyama, Y. (2011) · Hepatology · doi:10.1002/hep.24387 · Cited by 44
RNA binding protein HuR regulates the expression of ABCA1
Ramírez, C. M., Lin, C., Abdelmohsen, K., Goedeke, L., Yoon, J., Madrigal‐Matute, J., Martín-Ventura, J. L., Vo, D. T., Uren, P. J., Penalva, L. O. F., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m044925 · Cited by 44
MicroRNAs: At the Interface of Metabolic Pathways and Inflammatory Responses by Macrophages
Nelson, M. C., & O’Connell, R. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01797 · Cited by 45
MicroRNAs and Circular RNAs in Lipoprotein Metabolism
Fernández‐Tussy, P., Ruz‐Maldonado, I., & Fernandez-Hernando, C. F. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00934-3 · Cited by 44
The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs
DiMarco, D. M., & Fernández, M. L. (2015) · Biology · doi:10.3390/biology4030494 · Cited by 44
Xu, F., Wang, X., Feng, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104371 · Cited by 44
Mouse models and the interpretation of human GWAS in type 2 diabetes and obesity
Cox, R., & CHURCH, C. D. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.000414 · Cited by 46
The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
Sethupathy, P. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0745-3 · Cited by 44
Shao, D., Lian, Z., Di, Y., Zhang, L., Rajoka, M. S. R., Zhang, Y., Kong, J., Jiang, C., & Shi, J. (2018) · npj Science of Food · doi:10.1038/s41538-018-0022-8 · Cited by 49
Banno, A., Wang, J., Okada, K., Mori, R., Mijiti, M., & Nagaoka, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-56031-8 · Cited by 46
Ma, W., Ding, H., Gong, X., Liu, Z., Lin, Y., Zhang, Z., & Lin, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.034 · Cited by 43
HDL miR -ed Down by SREBP Introns
Brown, M. S., Ye, J., & Goldstein, J. L. (2010) · Science · doi:10.1126/science.1192409 · Cited by 43
Chistiakov, D. A., Sobenin, I. A., & Orekhov, A. N. (2012) · Drug Delivery · doi:10.3109/10717544.2012.738436 · Cited by 43
Xu, J., Hu, G., Lu, M. H., Xiong, Y., Li, Q., Chang, C. C. Y., Song, B., Chang, T., & Li, B.-L. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt096 · Cited by 42
miRNA and cholesterol homeostasis
Jeon, T.-I., & Osborne, T. F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.005 · Cited by 43
Gadde, S., & Rayner, K. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307481 · Cited by 44
MicroRNAs as the actors in the atherosclerosis scenario
Hajibabaie, F., Kouhpayeh, S., Mirian, M., Rahimmanesh, I., Boshtam, M., Sadeghian, L., Gheibi, A., Khanahmad, H., & Shariati, L. (2019) · Journal of physiology and biochemistry · doi:10.1007/s13105-019-00710-7 · Cited by 42
Han, Q., Su, D., Shi, C., Liu, P., Wang, Y., Zhu, B., & Xia, X. (2020) · Food & Function · doi:10.1039/c9fo02471a · Cited by 44
MicroRNA regulation of cholesterol metabolism
Citrin, K. M., Fernandez-Hernando, C. F., & Suárez, Y. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14566 · Cited by 45
Lacaria, M., Saha, P., Potocki, L., Bi, W., Yan, J., Girirajan, S., Burns, B., Elsea, S. H., Walz, K., Chan, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002713 · Cited by 43
mir-11 limits the proapoptotic function of its host gene, dE2f1Preprint
Truscott, M., Islam, A. B. M. M. K., López-Bigas, N., & Frolov, M. V. (2011) · Genes & Development · doi:10.1101/gad.16947411 · Cited by 44
DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer
Yin, H., Song, P., Su, R. J., Yang, G., Dong, L., Luo, M., Wang, B., Gong, B., Liu, C., Song, W., et al. (2016) · Scientific Reports · doi:10.1038/srep18824 · Cited by 43
Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective
Bhattarai, A., Likos, E., Weyman, C. M., & Shukla, G. C. (2021) · Steroids · doi:10.1016/j.steroids.2021.108878 · Cited by 44
Katsi, V. K., Papakonstantinou, I. P., & Tsioufis, K. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411786 · Cited by 43
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 42
Liu, S., Wu, Z., Guo, S., et al. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.11.048 · Cited by 42
Losada, L., Barker, B. M., Pakala, S., Pakala, S., Joardar, V., Zafar, N., Mounaud, S., Fedorova, N., Nierman, W. C., & Cramer, R. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9779-8 · Cited by 38
“INSIG genes are well studied in mammals in relation to SREBP regulation [10–12] and ncRNA regulation of sterol and lipid metabolism by miR-33 and miR-96 of INSIG-1 was recently described in humans [13, 14].”
BackgroundMicroRNAs in Cardiometabolic Disease
Najafi-Shoushtari, S. H. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0179-y · Cited by 41
Self-citationPacheco, M. P., John, E., Kaoma, T., Heinäniemi, M., Nicot, N., Vallar, L., Bueb, J., Sinkkonen, L., & Sauter, T. (2015) · BMC Genomics · doi:10.1186/s12864-015-1984-4 · Cited by 42
Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets
Cole, J. E., Mitra, A. T., & Monaco, C. G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.149 · Cited by 40
Christian, P., & Su, Q. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00194.2014 · Cited by 42
Mok, E. H. K., & Lee, T. K. (2020) · Cancers · doi:10.3390/cancers12061410 · Cited by 43
Ma, C., Zhang, J., Yang, S., Hua, Y., Su, J., Shang, Y., Wang, Z., Feng, K., Zhang, J., Yang, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.610550 · Cited by 41
Ortega, R., Liu, B., & Persaud, S. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310777 · Cited by 45
HDL—A molecule with a multi-faceted role in coronary artery disease
Arora, S., Patra, S. K., & Saini, R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.021 · Cited by 43
Implications of microRNAs in the pathogenesis of diabetes
Park, S., Jeong, H.-J., Yang, W., & Lee, W. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0017-6 · Cited by 41
MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
Norata, G. D., Sala, F., Catapano, A. L., & Fernandez-Hernando, C. F. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.019 · Cited by 40
Micromanaging metabolism—a role for miRNAs in teleost energy metabolism
Mennigen, J. A. (2015) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2015.09.001 · Cited by 39
Therapeutic Advances in MicroRNA Targeting
Montgomery, R. L., & van Rooij, E. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f603d0 · Cited by 40
Mobuchon, L., Marthey, S., Boussaha, M., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1471-y · Cited by 39
Zhao, G.-J., Tang, S.-L., Lv, Y.-C., Ouyang, X.-P., He, P.-P., Yao, F., Tang, Y.-Y., Zhang, M., Tang, Y.-L., Tang, D.-P., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.093 · Cited by 39
Chen, Z. B., Martin, M., Zhao, L., & Shyy, J. Y.-J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000107 · Cited by 40
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
Karatas, O., Wang, J.-H., Shao, L.-J., Ozen, M., Zhang, Y.-Q., Creighton, C., & Ittmann, M. (2017) · OncoTarget · doi:10.18632/oncotarget.19521 · Cited by 40
Lu, R., Qin, C., Yang, F., Zhang, W., Zhang, Y., Yang, G., Yang, L., Meng, X., Yan, X., & Nie, G.-X. (2020) · Fish Physiology and Biochemistry · doi:10.1007/s10695-020-00819-3 · Cited by 39
Mandolini, C., Santovito, D., Marcantonio, P., Buttitta, F., Bucci, M., Ucchino, S., Mezzetti, A., & Cipollone, F. (2015) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.09.005 · Cited by 38
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33
Allen, R. M., Marquart, T. J., Jesse, J. J., & Baldán, Á. (2014) · Circulation Research · doi:10.1161/circresaha.115.303100 · Cited by 38
Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment
Mandal, C. C. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000316 · Cited by 38
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease
Yu, J., Peng, J., Luan, Z., Zheng, F., & Su, W. (2019) · Molecules · doi:10.3390/molecules24020230 · Cited by 40
MicroRNA-33 in atherosclerosis etiology and pathophysiology
Chen, W., Zhang, M., Zhao, G., Fu, Y., Zhang, D., Zhu, H., & Tang, C. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.025 · Cited by 39
Jia, L., Song, N., Yang, G.-L., Ma, Y.-X., Li, X.-T., Lu, R., Cao, H., Zhang, N., Zhu, M.-L., Wang, J., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5133 · Cited by 36
Chen, W., Sheu, W. H., Tseng, P., Lee, T., Lee, W., Chang, P., & Chiang, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154672 · Cited by 37
Erhartova, D., Cahová, M., Daňková, H., Heczková, M., Míková, I., Sticová, E., Spicak, J., Šeda, O., & Trunec̃ka, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224820 · Cited by 34
HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism
Ogura, M. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.07.004 · Cited by 44
Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1.
He, Y., Lin, L., Cao, J., Mao, X., Qu, Y., & Xi, B. (2015) · PubMed · Cited by 37
The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer
Munir, M. T., Ponce, C., Powell, C. A., Tarafdar, K., Yanagita, T., Choudhury, M., Gollahon, L., & Rahman, S. M. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.05.001 · Cited by 37
miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Price, N. L., Goedeke, L., Suárez, Y., & Fernández‐Hernando, C. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012606 · Cited by 36
“…cell types and tissues and work together with their host genes to control lipid homeostasis (Gerin et al, 2010; Horie et al, 2010; Marquart et al, 2010; Najafi-Shoushtari et al, 2010; Rayner et al, 2010; Davalos et al, 2011; Goedeke et al, 2013; Shao et al, 2014; Shao et al, 2019; Zhu et al, 2020).”
BackgroundInfluentialWang, Y., Zhou, X., Shan, B., Han, J., Wang, F., Fan, X., Lv, Y., Chang, L., & Liu, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4296 · Cited by 36
Zhang, Q., Xie, D., Wang, S., You, C., Monroig, Ó., Tocher, D. R., & Li, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.009 · Cited by 37
Self-citation
Metadata
- Authors
- Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Näär, Anders M.
- ORCID
- Venue
- Science
- Published
- 2010-06-18
- Volume
- 328
- Issue
- 5985
- Pages
- 1566-1569
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3840500
- OpenAlex
- W2102901373
- Semantic Scholar
- 8e1f87e5a8c468d11cb938b52c20c8e6954402ce
- Cited by
- 957
- References
- 31
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 24 · 2023: 47 · 2022: 41 · 2021: 56 · 2020: 50 · 2019: 65 · 2018: 66 · 2017: 59 · 2016: 86 · 2015: 88 · 2014: 85 · 2013: 92 · 2012: 73
- FWCI
- 80.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM071449)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK084459, R01 DK48873, P30-DK34854, R01DK056626, R01 DK56626, R37DK048873, P30DK034854, R01DK048873)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- miR-33, cholesterol homeostasis, ABCA1, reverse cholesterol transport, HDL synthesis, cholesterol efflux, post-transcriptional regulation, antisense oligonucleotides, locked nucleic acid, cholesterol biosynthesis, cardiometabolic disease
- MeSH terms
- Animals, Cell Line, Cholesterol, Diet, Gene Expression Regulation, Homeostasis, Humans, Introns, Cholesterol, HDL, Liver, Macrophages, Mice, Inbred C57BL, Up-Regulation, Oligonucleotides, Antisense, ATP-Binding Cassette Transporters, 3' Untranslated Regions, RNA Interference, MicroRNAs, Mice, Sterol Regulatory Element Binding Proteins, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
